Patents by Inventor Francesca Tallia

Francesca Tallia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10787542
    Abstract: The invention relates to inorganic-organic hybrid materials comprising interpenetrated organic and inorganic components, wherein the organic component comprises polymer chains formed at least in part by ring-opening polymerization of a cyclic monomer, and processes for the production thereof.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: September 29, 2020
    Assignees: IMPERIAL COLLEGE INNOVATIONS LIMITED, UNIVERSITÀ DEGLI STUDI DI MILANO—BICOCCA
    Inventors: Francesca Tallia, Julian Raymond Jones, Laura Francesca Cipolla, Laura Russo, Gloria Ruth Young
  • Publication number: 20190112422
    Abstract: The invention relates to inorganic-organic hybrid materials comprising interpenetrated organic and inorganic components, wherein the organic component comprises polymer chains formed at least in part by ring-opening polymerization of a cyclic monomer, and processes for the production thereof.
    Type: Application
    Filed: March 31, 2017
    Publication date: April 18, 2019
    Inventors: Francesca Tallia, Julian Raymond Jones, Laura Francesca Cipolla, Laura Russo, Gloria Ruth Young
  • Publication number: 20130059013
    Abstract: An injectable composition for bone filling or consolidation, for use in surgery or therapy, characterized in that it comprises a biocompatible powdery material, which is hardenable or cross-linkable and selected from calcium sulphate hemi-hydrate and polymethylmethacrylate, a hardening or cross-linking agent for said material and a porous silica-based powdery material, having a specific surface area higher than 100 m2/g, which comprises a mesoporous bioactive glass, obtainable/achievable by a sol-gel method with the addition of a surfactant as structure-directing agent for pores formation, comprising an oxide mixture containing: SiO2: from 60 to 85% by moles CaO: from 10 to 30% by moles P2O5: from 2 to 10% by moles said composition, when applied to an affected area of a patient, being adapted to form a composite material wherein said hardenable or cross-linkable material constitutes a matrix and said mesoporous bioactive glass constitutes a dispersed phase in said matrix.
    Type: Application
    Filed: May 12, 2011
    Publication date: March 7, 2013
    Applicant: POLITECNICO DI TORINO
    Inventors: Chiara Vitale Brovarone, Enrica Verne', Mauro Bergui, Barbara Onida, Francesco Baino, Marta Miola, Sara Ferraris, Francesca Tallia